Olivia Simma

779 total citations
11 papers, 622 citations indexed

About

Olivia Simma is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Olivia Simma has authored 11 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Oncology and 2 papers in Genetics. Recurrent topics in Olivia Simma's work include Immune Cell Function and Interaction (8 papers), Cytokine Signaling Pathways and Interactions (4 papers) and CAR-T cell therapy research (3 papers). Olivia Simma is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Cytokine Signaling Pathways and Interactions (4 papers) and CAR-T cell therapy research (3 papers). Olivia Simma collaborates with scholars based in Austria, Germany and Czechia. Olivia Simma's co-authors include Veronika Sexl, Wolfgang Warsch, Dagmar Stoiber, Eva Eckelhart, Eva Zebedin, Andrea Hoelbl‐Kovacic, Thomas Rülicke, Thomas Kolbe, Boris Kovačic and Richard Moriggl and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Olivia Simma

11 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivia Simma Austria 11 410 262 145 121 93 11 622
Junichiro Yuda Japan 10 289 0.7× 268 1.0× 198 1.4× 180 1.5× 63 0.7× 43 566
Mayumi Onishi Japan 6 196 0.5× 282 1.1× 233 1.6× 87 0.7× 66 0.7× 7 509
Nora Ku United States 11 202 0.5× 168 0.6× 128 0.9× 250 2.1× 99 1.1× 24 584
Annalisa Rossini Italy 5 197 0.5× 192 0.7× 226 1.6× 180 1.5× 43 0.5× 8 499
Rhoda Eniafe United States 12 339 0.8× 209 0.8× 132 0.9× 268 2.2× 89 1.0× 18 529
Nisha Shah United States 13 207 0.5× 143 0.5× 230 1.6× 174 1.4× 51 0.5× 18 503
Chiara Gentilini Germany 14 605 1.5× 396 1.5× 177 1.2× 252 2.1× 99 1.1× 24 932
Tina Nuebling Germany 9 270 0.7× 247 0.9× 132 0.9× 106 0.9× 37 0.4× 13 455
Marijke Valkhof Netherlands 10 250 0.6× 90 0.3× 204 1.4× 185 1.5× 60 0.6× 14 516
Françoise Mallet France 12 646 1.6× 343 1.3× 201 1.4× 302 2.5× 67 0.7× 17 905

Countries citing papers authored by Olivia Simma

Since Specialization
Citations

This map shows the geographic impact of Olivia Simma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Simma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Simma more than expected).

Fields of papers citing papers by Olivia Simma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia Simma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Simma. The network helps show where Olivia Simma may publish in the future.

Co-authorship network of co-authors of Olivia Simma

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia Simma. A scholar is included among the top collaborators of Olivia Simma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia Simma. Olivia Simma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mizutani, Tatsuaki, Eva Maria Putz, Nadine Moritz, et al.. (2012). Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance. OncoImmunology. 1(7). 1027–1037. 49 indexed citations
2.
Putz, Eva Maria, Michaela Prchal‐Murphy, Olivia Simma, et al.. (2012). PI3Kδ Is Essential for Tumor Clearance Mediated by Cytotoxic T Lymphocytes. PLoS ONE. 7(7). e40852–e40852. 31 indexed citations
3.
Kollmann, Karoline, Gerwin Heller, René G. Ott, et al.. (2011). c-JUN promotes BCR-ABL–induced lymphoid leukemia by inhibiting methylation of the 5′ region of Cdk6. Blood. 117(15). 4065–4075. 27 indexed citations
4.
Schuster, Christian, Angelika Berger, Eva Maria Putz, et al.. (2011). The cooperating mutation or “second hit” determines the immunologic visibility toward MYC-induced murine lymphomas. Blood. 118(17). 4635–4645. 28 indexed citations
5.
Eckelhart, Eva, Wolfgang Warsch, Eva Zebedin, et al.. (2010). A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood. 117(5). 1565–1573. 169 indexed citations
6.
Pilz, Andreas, Olivia Simma, Karen Lingnau, et al.. (2009). Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity. Vaccine. 27. G17–G20. 35 indexed citations
7.
Pilz, Andreas, Silvia Stockinger, Olivia Simma, et al.. (2009). Dendritic Cells Require STAT-1 Phosphorylated at Its Transactivating Domain for the Induction of Peptide-Specific CTL. The Journal of Immunology. 183(4). 2286–2293. 30 indexed citations
8.
Zebedin, Eva, Olivia Simma, Christian Schuster, et al.. (2008). Leukemic challenge unmasks a requirement for PI3Kδ in NK cell–mediated tumor surveillance. Blood. 112(12). 4655–4664. 38 indexed citations
9.
Simma, Olivia, Eva Zebedin, Carola Schellack, et al.. (2008). Identification of an Indispensable Role for Tyrosine Kinase 2 in CTL-Mediated Tumor Surveillance. Cancer Research. 69(1). 203–211. 28 indexed citations
10.
Ott, René G., Olivia Simma, Karoline Kollmann, et al.. (2007). JunB is a gatekeeper for B-lymphoid leukemia. Oncogene. 26(33). 4863–4871. 19 indexed citations
11.
Hoelbl‐Kovacic, Andrea, Boris Kovačic, Marc A. Kerenyi, et al.. (2006). Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood. 107(12). 4898–4906. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026